当前位置: 首页 > 期刊 > 《健康大视野·医学分册》 > 201919
编号:13531778
血清白蛋白在老年人脓毒症临床价值研究(3)
http://www.100md.com 2019年10月1日 《健康大视野》 201919
     [7] Seymour C W , Liu V X , Iwashyna T J , et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. The Journal of the American Medical Association,2016,315(8):762-774.

    [8] 江伟, 杜斌. 中国脓毒症流行病学现状[J]. 医学研究生学报, 2019, 32(01):11-14.

    [9] Rhodes A , Evans L E , Alhazzani W , et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock[J]. Critical Care Medicine, 2017, 45(3):1.

    [10] Huang Y , Alzahrani N A , Chua T C , et al. Impacts of Preoperative Serum Albumin Level on Outcomes of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy[J]. Annals of Surgical Oncology, 2016, 23(8):2411-2418.

    [11] Procalcitonin and mortality in status epilepticus: an observational cohort study[J]. Critical Care, 2015, 19(1):361.

    [12] 韓涛, 邓秋明, 万献尧. 脓毒症患者低白蛋白血症研究进展[J]. 中华医学杂志, 2017, 97(3):228-231.

    [13] Sadaka F , Ethmaneabouelmaali C , Cytron M A , et al. Predicti-ng Mortality of Patients With Sepsis: A Comparison of APACHE II and APACHE III Scoring Systems[J]. Journal of Clinical Medicine Research, 2017, 9(11):907-910.

    [14] 何美娜, 招晓俊. 血乳酸水平和乳酸清除率评估脓毒血症的预后研究[J]. 解放军预防医学杂志, 2019, 37(01):97-99.

    [15] 张志彪, 严丽. PCT、LAC/ScvO_2比值对脓毒症患者病情危重程度与预后的评估价值[J]. 临床急诊杂志, 2019, 20(2):119-123., 百拇医药(孙磊 张晴 王智博)
上一页1 2 3